Psychedelics Proven to Reduce Anxiety and Depression Symptoms
Recent research has shown that taking LSD can reduce levels of anxiety and depression in people suffering from these conditions up to 16 weeks after administration. This breakthrough study opens up new possibilities for treating mental health issues using psychedelics instead of traditional pharmaceuticals in the future.
Jan. 06, 2023 4:11AM
Generated in 17.6 seconds
A colorful illustration depicting a person surrounded by psychedelic colors representing their improved mental state due to taking LSD as part of an RCT trial.
In a recent randomized controlled trial, researchers have found that the use of lysergic acid diethylamide (LSD) can produce long-lasting and notable reductions in anxiety and comorbid depression symptoms up to 16 weeks. This study is the first of its kind to demonstrate such promising results for psychedelic drugs as a potential treatment for mental health issues. The double-blinded, placebo-controlled trial was conducted with a sample size of 24 participants who were all diagnosed with anxiety disorders or major depressive disorder. The participants were randomly assigned either LSD or a placebo, and then assessed at 4, 8, 12, and 16 weeks after the initial administration. The results showed that those who received LSD had significantly lower levels of anxiety and depression than those who received the placebo. This groundbreaking research has opened up new possibilities for treating mental health conditions using psychedelics instead of traditional pharmaceuticals. While more research is needed to further understand how these drugs work on different populations, this initial study provides hope that psychedelic drugs could be used as an effective treatment option for people suffering from anxiety and depression in the future.